title: Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
authors: Department of Nephrology, Hospital Universitario La Fe, Valencia, Spain.
authors: L M
authors: LM
authors: Pallardó
authors: P
authors: P
authors: Sánchez
authors: J
authors: J
authors: Sánchez
authors: J
authors: J
authors: García
authors: E
authors: E
authors: Orero
authors: I
authors: I
authors: Beneyto
authors: J M
authors: JM
authors: Cruz
mesh_terms: D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D016016:Proportional Hazards Models; D012307:Risk Factors; D015996:Survival Rate
chemical_list: D006680:HLA Antigens; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone